Search

Paul V. Ward

Examiner (ID: 13921, Phone: (571)272-2909 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1624, 1623, 1622
Total Applications
2552
Issued Applications
1846
Pending Applications
195
Abandoned Applications
548

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18216392 [patent_doc_number] => 11591314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Process for preparing tetrahydrocarbazole carboxamide compound [patent_app_type] => utility [patent_app_number] => 17/101411 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17983 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101411 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/101411
Process for preparing tetrahydrocarbazole carboxamide compound Nov 22, 2020 Issued
Array ( [id] => 18399298 [patent_doc_number] => 11661424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-30 [patent_title] => Process for preparing BTK inhibitors [patent_app_type] => utility [patent_app_number] => 17/102086 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34518 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102086 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/102086
Process for preparing BTK inhibitors Nov 22, 2020 Issued
Array ( [id] => 18056583 [patent_doc_number] => 20220387669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT [patent_app_type] => utility [patent_app_number] => 17/775779 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1708 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775779 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/775779
CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT Nov 18, 2020 Pending
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 18887665 [patent_doc_number] => 11866426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Benzothiazole compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 17/098880 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31173 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3969 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098880 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098880
Benzothiazole compounds and uses thereof Nov 15, 2020 Issued
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 18075776 [patent_doc_number] => 20220401388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => METHODS FOR USING LOW-DOSE COLCHICINE AFTER MYOCARDIAL INFARCTION [patent_app_type] => utility [patent_app_number] => 17/776690 [patent_app_country] => US [patent_app_date] => 2020-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19440 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776690 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/776690
Methods for using low-dose colchicine after myocardial infarction Nov 12, 2020 Issued
Array ( [id] => 18590191 [patent_doc_number] => 11739071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-29 [patent_title] => Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors [patent_app_type] => utility [patent_app_number] => 17/096349 [patent_app_country] => US [patent_app_date] => 2020-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26071 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096349 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/096349
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Nov 11, 2020 Issued
Array ( [id] => 16868430 [patent_doc_number] => 20210161897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/094893 [patent_app_country] => US [patent_app_date] => 2020-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7356 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094893 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/094893
EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER Nov 10, 2020 Abandoned
Array ( [id] => 16688286 [patent_doc_number] => 20210070762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => SYNTHESIS OF COELENTERAZINE [patent_app_type] => utility [patent_app_number] => 17/089573 [patent_app_country] => US [patent_app_date] => 2020-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16949 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/089573
Synthesis of coelenterazine Nov 3, 2020 Issued
Array ( [id] => 16839920 [patent_doc_number] => 20210147932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR [patent_app_type] => utility [patent_app_number] => 17/088119 [patent_app_country] => US [patent_app_date] => 2020-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26951 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17088119 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/088119
FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR Nov 2, 2020 Abandoned
Array ( [id] => 17385525 [patent_doc_number] => 20220033377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline [patent_app_type] => utility [patent_app_number] => 17/086666 [patent_app_country] => US [patent_app_date] => 2020-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20708 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086666 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/086666
Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline Nov 1, 2020 Abandoned
Array ( [id] => 18013263 [patent_doc_number] => 11505545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-22 [patent_title] => Anthelmintic quinoline-3-carboxamide derivatives [patent_app_type] => utility [patent_app_number] => 17/085880 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 141386 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085880 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/085880
Anthelmintic quinoline-3-carboxamide derivatives Oct 29, 2020 Issued
Array ( [id] => 20226270 [patent_doc_number] => 12414909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-16 [patent_title] => Polysaccharide-based gelled foam [patent_app_type] => utility [patent_app_number] => 17/772676 [patent_app_country] => US [patent_app_date] => 2020-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3194 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772676 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/772676
Polysaccharide-based gelled foam Oct 26, 2020 Issued
Array ( [id] => 16612117 [patent_doc_number] => 20210030770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => LITHIUM CHOLESTEROL COMPOSITIONS, INCLUDING, BUT NOT LIMITED TO LITHIUM CHOLESTEROL SULFATE COMPOSITIONS, AND METHODS OF TREATMENT FOR ALZHEIMER'S DISEASE AND NEUROLOGICAL DISORDERS [patent_app_type] => utility [patent_app_number] => 17/076081 [patent_app_country] => US [patent_app_date] => 2020-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076081 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/076081
LITHIUM CHOLESTEROL COMPOSITIONS, INCLUDING, BUT NOT LIMITED TO LITHIUM CHOLESTEROL SULFATE COMPOSITIONS, AND METHODS OF TREATMENT FOR ALZHEIMER'S DISEASE AND NEUROLOGICAL DISORDERS Oct 20, 2020 Abandoned
Array ( [id] => 16749904 [patent_doc_number] => 20210101913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => 2-OXOTHIATOLE COMPOUNDS HAVING ACTIVITY AS CPLA2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND HYPERPROLIFERATIVE DISORDERS [patent_app_type] => utility [patent_app_number] => 17/076554 [patent_app_country] => US [patent_app_date] => 2020-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10928 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076554 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/076554
2-OXOTHIATOLE COMPOUNDS HAVING ACTIVITY AS CPLA2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND HYPERPROLIFERATIVE DISORDERS Oct 20, 2020 Abandoned
Array ( [id] => 19186231 [patent_doc_number] => 20240165144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => COMPOSITIONS AND METHODS FOR MODULATING INNATE IMMUNE SIGNALING PATHWAYS [patent_app_type] => utility [patent_app_number] => 17/769517 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26456 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769517 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/769517
COMPOSITIONS AND METHODS FOR MODULATING INNATE IMMUNE SIGNALING PATHWAYS Oct 15, 2020 Abandoned
Array ( [id] => 18056504 [patent_doc_number] => 20220387590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => PHOTOLYTIC COMPOUNDS AND TRIPLET-TRIPLET ANNIHILATION MEDIATED PHOTOLYSIS [patent_app_type] => utility [patent_app_number] => 17/765251 [patent_app_country] => US [patent_app_date] => 2020-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765251 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/765251
Photolytic compounds and triplet-triplet annihilation mediated photolysis Oct 6, 2020 Issued
Menu